CoChat

Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery

Abou-Setta, Ahmed M, Houston, Brett, Al-Inany, Hesham G, Farquhar, Cindy · 2013 · Cochrane Database of Systematic Reviews
Cited by 69

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Various options exist for treating endometriosis, including surgical, medical, such as ovarian suppression, or a combination of these strategies. Surgical treatment of endometriosis aims to remove visible areas of endometriosis. The aim of medical therapy is to inhibit growth of endometriotic implants by induction of a hypo-estrogenic state. Treatment with a hormone-releasing intrauterine device, using levonorgestrel (LNG-IUD), has also been suggested. OBJECTIVES: To determine whether postoperative LNG-IUD insertion in women with endometriosis improves pain and reduces recurrence of symptoms compared with no postoperative treatment, postoperative insertion of a placebo, or postoperative therapy. SEARCH METHODS: The following databases were searched from inception to June 2012: Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, PsycINFO, CINAHL, and the World Health Organization (WHO) International Clinical Trials Registry Platform. EMBASE was searched from 2010 to June 2012. The citation lists of relevant publications, review articles, abstracts of scientific meetings, and included studies were also searched. SELECTION CRITERIA: Trials were included if they compared women undergoing surgical treatment for endometriosis with uterine preservation and then randomised within three months to LNG-IUD insertion versus no postoperative treatment, placebo (inert IUD), or other treatment. Diagnostic laparoscopy alone was not considered suitable treatment. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies for inclusion and extracted data to allow for an intention-to-treat analysis. For dichotomous data, the risk ratio (RR) and 95% confidence interval (CI) were calculated using the Mantel-Haenszel random-effects method. For continuous data, the mean difference (MD) and 95% CI were calculated using the inverse variance random-effects method. MAIN RESULTS: Three randomised controlled trials were included. In two trials, there was a statistically significant reduction in the recurrence of painful periods in the LNG-IUD group compared with expectant management (RR 0.22, 95% CI 0.08 to 0.60, 95 women, I(2) = 0%, moderate strength of evidence). The proportion of women who were satisfied with their treatment was also higher in the LNG-IUD group but did not reach statistical significance (RR 1.21, 95% CI 0.80 to 1.82, 95 women, I(2) = 0%). The number of women reporting a change in menstruation was significantly higher in the LNG-IUD group (RR 37.80, 95% CI 5.40 to 264.60, 95 women, I(2) = 0%) but the number of women not completing the allocated treatment did not differ between groups (RR 0.66, 95% CI 0.08 to 5.25, I(2) = 43%).In one trial, women receiving LNG-IUD noted lower pain scores compared with women receiving gonadotrophin-releasing hormone agonists (MD -0.16, 95% CI -2.02 to 1.70, 40 women) but this did not reach statistical significance. AUTHORS' CONCLUSIONS: There is limited but consistent evidence showing that postoperative LNG-IUD use reduces the recurrence of painful periods in women with endometriosis. Further well-designed RCTs are needed to confirm these findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd005072.pub3

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 39

  1. Frontino G Vercellini P De Giorgi O Aimi G Zaina B Crosignani P G Levonorgestrel-releasing intrauterine device (Lng-IUD) versus expectant management after conservative surgery for symptomatic endometriosis. A pilot study Fertility and Sterility 2002 · DOI
  2. Elovainio, 2007, Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system, International Journal of Behavioral Medicine, 14, 70, 10.1007/BF03004171 · DOI
  3. Ferreira, 2010, Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue, Contraception., 81, 117, 10.1016/j.contraception.2009.08.003 · DOI
  4. Gomes, 2007, The levonorgestrel-releasing intrauterine system and endometriosis staging, Fertility and Sterility, 87, 1231, 10.1016/j.fertnstert.2006.11.044 · DOI
  5. Hurskainen, 2004, Clinical Outcomes and Costs With the Levonorgestrel-Releasing Intrauterine System or Hysterectomy for Treatment of Menorrhagia: Randomized trial 5-year follow-up, JAMA, 291, 1456, 10.1001/jama.291.12.1456 · DOI · Paper page
  6. Lockhat, 2005, Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel, Fertility and Sterility, 83, 398, 10.1016/j.fertnstert.2004.07.961 · DOI
  7. Manetta, 2008, Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist, Ultrasound in Medicine & Biology, 34, 1914, 10.1016/j.ultrasmedbio.2008.04.013 · DOI
  8. Rosa, 2005, Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterinearteries, in women with pelvic endometriosis, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 123, S39, 10.1016/S0301-2115(05)80319-7 · doi:10.1016/s0301-2115(05)80319-7
  9. Vieira, 2007, Comparative study of the influence of the levonorgestrel intra-uterine system and the GnRH analogues on cardiovascular risk markers in patients with endometriosis, Fertility and Sterility, 88, S211, 10.1016/j.fertnstert.2007.07.720 · DOI
  10. Xu, 2011, [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study], Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal], 91, 1047
  11. Alhamdan, 2010, Mirena intra-uterine system: does it improve long term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial, Reviews on Recent Clinical Trials., 5, 143, 10.2174/157488710792007301 · doi:10.2174/157488710792007301
  12. Anpalagan, 2008, Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?, Journal of Minimally Invasive Gynecology, 15, 663, 10.1016/j.jmig.2008.07.008 · DOI
  13. American Society for Reproductive Medicine, 2006, Endometriosis and infertility: The Practice Committee of the American Society for Reproductive Medicine, Fertility and Sterility, 86, 156
  14. Bahamondes, 2007, Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea, Contraception, 75, S134, 10.1016/j.contraception.2006.12.008 · DOI
  15. Bazot, 2004, Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis, Ultrasound in Obstetrics & Gynecology, 24, 180, 10.1002/uog.1108 · DOI · Paper page
  16. Carter, 1994, Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain, Journal of the American Association of Gynecologic Laparoscopists, 2, 43, 10.1016/S1074-3804(05)80830-8 · DOI · Paper page
  17. Crosignani, 1996, Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis, Fertility and Sterility, 66, 706, 10.1016/S0015-0282(16)58622-1 · DOI · Paper page
  18. Crosignani, 1997, Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding, Obstetrics and Gynecology, 90, 257, 10.1016/S0029-7844(97)00226-3 · DOI · Paper page
  19. Du, 1999, Serum levels of levonorgestrel during long-term use of Norplant, Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics & Gynecology], 34, 363
  20. Duepree, 2002, Laparoscopic resection of deep pelvic endometriosis with rectosigmoid involvement, Journal of the American College of Surgery, 195, 754, 10.1016/S1072-7515(02)01341-8 · DOI · Paper page
  21. Ford, 2004, Pain, quality of life and complications following the radical resection of rectovaginal endometriosis, British Journal of Obstetrics and Gynaecology, 111, 353, 10.1111/j.1471-0528.2004.00093.x · DOI · Paper page
  22. Furness, 2004, Pre and post operative medical therapy for endometriosis surgery, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003678.pub2 · DOI · Paper page
  23. Henderson, 1991, The role of definitive surgery and hormone replacement therapy in the treatment of endometriosis, 275, 10.1007/978-94-011-3864-2_15 · DOI
  24. Higgins, 2011. Available from www.cochrane-handbook.org, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]
  25. Jacobson, 2001, Laparoscopic surgery for pelvic pain associated with endometriosis, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001300 · DOI · Paper page
  26. Lefebvre, 2002, SOGC clinical guidelines. Hysterectomy, Journal of Obstetrics and Gynaecology Canada, 24, 37
  27. Luciano, 1988, Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis, Obstetrics and Gynecology, 72, 323
  28. Maruo, 2001, Use of a levonorgestrel intrauterine system on proliferation and apoptosis in the endometrium, Human Reproduction, 16, 2103, 10.1093/humrep/16.10.2103 · DOI · Paper page
  29. Moghissi, 1999, Medical treatment of endometriosis, Clinical Obstetrics and Gynecology, 42, 620, 10.1097/00003081-199909000-00016 · DOI · Paper page
  30. Nicklin, 1999, Radical surgery for endometriosis, The Australian & New Zealand Journal of Obstetrics & Gynaecology, 39, 68, 10.1111/j.1479-828X.1999.tb03448.x · doi:10.1111/j.1479-828x.1999.tb03448.x
  31. Nilsson, 1978, Endometrial morphology of women using a D-norgestrel releasing intrauterine device, Fertility and Sterility, 29, 397, 10.1016/S0015-0282(16)43212-7 · DOI
  32. Overton, 2002, Epidemiology, 15
  33. Sagsveen, 2003, Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD001297 · DOI · Paper page
  34. Silverberg, 1986, Endometrial morphometry of women during long term use of levonorgestrel intrauterine system, International Journal of Gynecological Pathology, 5, 235, 10.1097/00004347-198609000-00005 · DOI · Paper page
  35. Vercellini, 1997, Progestins for symptomatic endometriosis: a critical analysis of the evidence, Fertility and Sterility, 68, 393, 10.1016/S0015-0282(97)00193-3 · DOI · Paper page
  36. Vercellini, 1998, Prevention of recurrences by postoperative medical treatment, 261
  37. Vercellini, 2000, Surgical management of endometriosis, Best Practice & Research. Clinical Obstetrics & Gynaecology, 14, 501, 10.1053/beog.1999.0088 · DOI
  38. Wellbery, 1999, Diagnosis and treatment of endometriosis, American Family Physician, 15, 1753-62, 1767-8
  39. Wright, 2000, The diagnosis and management of infiltrating nodular recto-vaginal endometriosis, Current Opinion in Obstetrics and Gynecology, 12, 283, 10.1097/00001703-200008000-00003 · DOI

Cited by

See all 69

Metadata

Authors
Abou-Setta, A. M., Houston, B., Al-Inany, H. G., & Farquhar, C.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2013-01-31
Issue
1
Pages
CD005072-CD005072
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W2107300092
Cited by
69
References
12
FWCI
7.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. https://app.cochat.ai/papers/10.1002/14651858.cd005072.pub3
The paper
Abou-Setta, A. M., Houston, B., Al-Inany, H. G., & Farquhar, C. (2013). Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd005072.pub3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.